Jonathan Wang

Bonovo Orthopedics, Inc. develops, manufactures and sells orthopedic implants and other orthopedic products. Its products includes spinal implants, artificial joints, pain management products and minimally invasive surgical solutions. The firm distributes Bonovo-branded products and serves as the distributor in China for other leading international orthopedic companies. Bonovo Orthopedics was founded by Hansen A. Yuan, Peter J. Slate, Xiao Ling Liang, Stephen H. Hochschuler, Frank M. Philips and Robert M. Scribner in July 2008 and is headquartered in Bloomington, MN.

Waterstone Pharmaceuticals, Inc. engages in the provision of discovery, development, and commercialization of innovative drugs for the treatment of liver and gastrointestinal diseases. The company was founded by Faming Zhang in 2008 and is headquartered in Carmel, IN.

GENEWIZ, Inc. provides research and development genomics services. Its services include Sanger deoxyribonucleic acid (DNA) sequencing, gene synthesis, next generation sequencing, molecular genetics, cloning and mutagenesis, plasmid DNA preparation, and good laboratory practice (GLP)-compliant services. The company was founded by Amy Liao and Steve Sun in 1999 and is headquartered in South Plainfield, NJ.

Maijin Biomedical Technology (Shanghai) Co. Ltd. provides immunology-related therapeutic areas in China. The company is headquartered in Shanghai, China.

Burril LLC (Burrill) is a private equity/venture capital firm founded in 1994 by G. Steven. The firm is headquartered in San Francisco, California.

OrbiMed Advisors LLC is an independent, SEC-registered investment advisor and hedge fund manager headquartered in New York City. It was founded by Sven Borho and Carl Gordon in 1989. The firm provides discretionary investment management services to US and non-US public and private funds.

Bridge Laboratories is a preclinical contract research organization (CRO) that provides US-level regulatory-compliant drug development services globally. Bridge is known for its extensive work in toxicology, including vaccines, and safety pharmacology. The company's AAALAC-accredited facility in China was among the first labs to perform GLP studies for clients worldwide. Bridge Laboratories gives drug development clients-biotech/pharmaceutical firms, government agencies and virtual companies with strong outsourcing needs-a CRO choice that can dramatically improve the speed and cost-effectiveness of their drug development research programs.